KRKorro Bio, Inc. KRRO · NASDAQ
$13.86 +4.21% (+$0.56)
- Market cap
- $204.1M
- Enterprise value
- $221.4M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 85.7x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -49.6%
- Gross margin
- 72.8%
- Net margin
- -4,477.1%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 2.36
- Free float
- 71.8%
About the company
Korro Bio, Inc. (KORO) is an American biotechnology company focused on developing innovative therapeutic approaches in the field of gene therapy and gene editing. With the goal of treating genetic diseases and other complex illnesses using advanced CRISPR technologies and gene editing, Korro Bio is a key player in the biomedicine sector. The company develops therapeutics aimed at modifying the genetic code, which may lead to new treatment options for patients. Korro Bio collaborates with leading scientific institutions and pharmaceutical companies to accelerate the development and commercialization of its products. Korro Bio, Inc. (KORO) shares could be suitable for investors looking to invest in biotechnology with potential for revolutionary advancements in treating genetic diseases.
Sector
Healthcare
Industry
Biotechnology
CEO
Ram Aiyar
Employees
57
Headquarters
Cambridge
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What to watch: Analysts expect revenue to fall by 95% this fiscal year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What to watch: It passes only 2 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number